Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

O Distler
KB Highland
M Gahlemann
A Azuma
A Fischer
MD Mayes
G Raghu
W Sauter
M Girard
M Alves
E Clerisme-Beaty
S Stowasser
K Tetzlaff
SENSCIS Trial Investigators

Related Research units

Institute for Neuroimmunology and Multiple Sclerosis

Bibliographical data

Original language	English
ISSN	0028-4793
DOIs	https://doi.org/10.1056/nejmoa1903076
Publication status	Published - 05.2019

Sitemap | Data protection | Imprint © Universitätsklinikum Hamburg-Eppendorf